Cytosorbents Corp
- Last sale
- Nov 11, 2026 · -7.03%
- Market cap
- $349.09M
- 62.84M shares
- Filings
- 979
Q2 2026+4.1% FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026derivedN/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026+90.5% FY25 yoy
- $349.09M
- —
- 9.4×
- —
- -2.66%
- —
Twelve months to Jun 30, 2026 · derived
Price
Nov 11, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $37,063,000 | reported | |
| FY 2024 | 2024-12-31 | $35,595,000 | reported | |
| FY 2023 | 2023-12-31 | $31,084,953 revised | reported | |
| FY 2022 | 2022-12-31 | $34,688,809 | reported | |
| FY 2021 | 2021-12-31 | $43,165,527 | reported | |
| FY 2020 | 2020-12-31 | $41,004,601 | reported | |
| FY 2019 | 2019-12-31 | $24,949,473 | reported | |
| FY 2018 | 2018-12-31 | $22,503,908 | reported | |
| FY 2017 | 2017-12-31 | $15,150,754 | reported | |
| FY 2016 | 2016-12-31 | $9,527,843 | reported | |
| FY 2015 | 2015-12-31 | $4,791,616 | reported | |
| FY 2014 | 2014-12-31 | $4,122,825 | reported |
Segments
Products
LineFY2023ShareChange
Total product sales$31.08M100%+5.9%
CytoSorb sales$31.02M100%+8.5%
Grant income$5.26M17%−1.2%
Other product sales$69.69K0.2%−91.1%
Total$31.08M
Surgical & medical instruments & apparatus
Cytosorbents Corp is the 72nd largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
SSIISS Innovations International, Inc.$42.5M105.7%28.5%$264.5MKRMDKORU Medical Systems, Inc.$41.1M22.2%6.4%$141.7MIDXGInterpace Biosciences, Inc.$38.7M17.5%63.5%$41.8MUTMDUtah Medical Products Inc$38.5M5.8%29.3%$210.7MRVPRetractable Technologies Inc$38.3M15.8%32.8%$17.7M
CTSOCytosorbents Corp (this company)$37.1M4.1%22.1%$349.1M
CLPTClearPoint Neuro, Inc.$37.0M17.8%69.1%$272.1MOBIOOrchestra BioMed Holdings, Inc.$33.5M1,169.2%157.4%$484.0MPREMPremier Air Charter Holdings Inc.$31.9M53.6%12.1%$11.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cytosorbents Corp · CIK 1175151 · Engraved from SEC EDGAR